Jan Best

2.4k total citations
56 papers, 1.2k citations indexed

About

Jan Best is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jan Best has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 32 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Jan Best's work include Liver Disease Diagnosis and Treatment (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Liver physiology and pathology (14 papers). Jan Best is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Liver physiology and pathology (14 papers). Jan Best collaborates with scholars based in Germany, United States and Belgium. Jan Best's co-authors include Ali Canbay, Guido Gerken, Leo A. van Grunsven, Lars P. Bechmann, Paul Manka, Jan‐Peter Sowa, Laurent Dollé, Svenja Sydor, Alexander Dechêne and Wing‐Kin Syn and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Jan Best

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Best Germany 20 688 551 264 261 214 56 1.2k
L. Trozzi Italy 20 877 1.3× 616 1.1× 555 2.1× 386 1.5× 198 0.9× 33 1.6k
Haibo Zhang China 13 644 0.9× 240 0.4× 350 1.3× 143 0.5× 184 0.9× 30 1.4k
Adrien Guillot Germany 20 919 1.3× 569 1.0× 491 1.9× 259 1.0× 138 0.6× 52 1.7k
Kei Moriya Japan 16 478 0.7× 347 0.6× 364 1.4× 203 0.8× 125 0.6× 61 1.2k
Sander Lefere Belgium 18 789 1.1× 391 0.7× 274 1.0× 260 1.0× 66 0.3× 55 1.2k
Yulia A. Nevzorova Germany 25 738 1.1× 494 0.9× 576 2.2× 251 1.0× 194 0.9× 50 1.6k
Hideyuki Kojima Japan 21 610 0.9× 447 0.8× 180 0.7× 231 0.9× 191 0.9× 57 1.2k
Suxian Zhao China 19 630 0.9× 374 0.7× 429 1.6× 168 0.6× 65 0.3× 58 1.2k
Ariel E. Feldstein United States 15 958 1.4× 544 1.0× 680 2.6× 237 0.9× 88 0.4× 23 1.7k
Carlos M. Rodríguez‐Ortigosa Spain 18 264 0.4× 273 0.5× 382 1.4× 234 0.9× 174 0.8× 37 1.1k

Countries citing papers authored by Jan Best

Since Specialization
Citations

This map shows the geographic impact of Jan Best's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Best with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Best more than expected).

Fields of papers citing papers by Jan Best

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Best. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Best. The network helps show where Jan Best may publish in the future.

Co-authorship network of co-authors of Jan Best

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Best. A scholar is included among the top collaborators of Jan Best based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Best. Jan Best is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schütte, Andreas, et al.. (2025). Serum IL-17F as a biomarker of infection-independent cirrhosis progression. Frontiers in Immunology. 16. 1671288–1671288.
2.
Best, Jan, Julia Kälsch, Marcin Krawczyk, et al.. (2025). Metabolische Dysfunktion-assoziierte steatotische Lebererkrankung und hepatozelluläres Karzinom. 20(2). 123–133.
3.
Sydor, Svenja, Jan Best, Martin Steinmetz, et al.. (2024). Religious intermittent fasting: Effects on liver health, metabolic markers, and gut microbiota in type 2 diabetes patients. Clinical Nutrition Open Science. 58. 370–383. 2 indexed citations
4.
Leyh, Catherine, Jason D. Coombes, Hartmut Schmidt, et al.. (2024). MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options. Journal of Personalized Medicine. 14(4). 370–370. 15 indexed citations
6.
Stippel, Dirk L., Ali Canbay, Dirk Nierhoff, et al.. (2024). COVID-19-associated secondary sclerosing cholangitis with liver transplantation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(2). 371–377.
7.
Broecker‐Preuss, Martina, Farhad Arzideh, Jan Best, et al.. (2023). Comparison of age- and sex-dependent reference limits derived from distinct sources for metabolic measurands in basic liver diagnostics. Zeitschrift für Gastroenterologie. 61(1). 50–59. 1 indexed citations
8.
Buechter, Matthias, Jan Best, Robert K. Gieseler, et al.. (2022). Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury. Digestive Diseases. 41(2). 259–267. 6 indexed citations
9.
Schotten, Clemens, Jan‐Peter Sowa, Paul Manka, et al.. (2021). GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals. 14(8). 735–735. 34 indexed citations
10.
Best, Jan, et al.. (2019). Implications of Immunotherapy in Hepatobiliary Tumors. Visceral Medicine. 35(1). 18–26. 1 indexed citations
11.
Müeller, Stefan, Jan Best, Judith Ertle, et al.. (2018). Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy. Cancer Immunology Immunotherapy. 67(5). 843–853. 17 indexed citations
12.
Verhulst, Stefaan, Jan Best, Wing‐Kin Syn, et al.. (2016). Infliximab and Dexamethasone Attenuate the Ductular Reaction in Mice. Scientific Reports. 6(1). 36586–36586. 6 indexed citations
13.
Theysohn, Jens, Marcus Ruhlmann, Stefan Müller, et al.. (2015). Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?. PLoS ONE. 10(9). e0137587–e0137587. 8 indexed citations
14.
Schelhorn, Juliane, Jan Best, Guido Gerken, et al.. (2015). Therapy Response Assessment after Radioembolization of Patients with Hepatocellular Carcinoma—Comparison of MR Imaging with Gadolinium Ethoxybenzyl Diethylenetriamine Penta-Acetic Acid and Gadobutrol. Journal of Vascular and Interventional Radiology. 26(7). 972–979. 5 indexed citations
15.
Best, Jan, Laurent Dollé, Paul Manka, et al.. (2013). Role of liver progenitors in acute liver injury. Frontiers in Physiology. 4. 258–258. 38 indexed citations
16.
Sydor, Svenja, Yanli Gu, Martin Schlattjan, et al.. (2012). Steatosis does not impair liver regeneration after partial hepatectomy. Laboratory Investigation. 93(1). 20–30. 43 indexed citations
17.
Dollé, Laurent, Jan Best, Christophe Empsen, et al.. (2011). Successful Isolation of Liver Progenitor Cells by Aldehyde Dehydrogenase Activity in Na"ve Mice. Hepatology. 55(2). 540–552. 45 indexed citations
18.
Best, Jan, et al.. (2009). Pregnancy-associated Sweet’s Syndrome in an Acute Episode of Ulcerative Colitis. Zeitschrift für Gastroenterologie. 47(8). 753–757. 8 indexed citations
19.
Sowa, Jan‐Peter, Jan Best, Tamás Benkö, et al.. (2008). Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration. World Journal of Gastroenterology. 14(46). 7093–7093. 20 indexed citations
20.
Canbay, Ali, et al.. (2006). Crohn’s Disease-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) Sensitizes for Severe Acute Hepatitis B Infection and Liver Failure. Zeitschrift für Gastroenterologie. 44(3). 245–248. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026